Pain
|
VAS and NPRS
|
6–8 weeks
|
Aasa et al. 2015 [30]
|
Good
|
− 0.13 [− 0.60, 0.34]
|
Trivial
|
Moderate
|
Atalay et al. 2017 [36]
|
Fair
|
− 0.33 [− 1.21, 0.56]
|
Small
|
Cai et al. 2015 [31]
|
Good
|
− 0.30 [− 0.85, 0.25]
|
Small
|
Suh et al. 2019 [35]
|
Good
|
− 0.50 [− 1.34, 0.34]
|
Moderate
|
Overall 6–8 weeks
| |
− 0.26 [− 0.56, 0.05]
|
Small
| |
12–16 weeks
|
Cortell-Tormo et al. 2018 [14]
|
Good
|
− 0.83 [− 1.67, 0.01]
|
Large
|
Strong
|
Hurley et al. 2015 [32]
|
Good
|
0.17 [− 0.16, 0.50]
|
Small
|
Jackson et al. 2011 [MA] [33]
|
Good
|
− 0.92 [− 1.68, − 0.16]
|
Large
|
Jackson et al. 2011 [OA] [33]
|
Good
|
− 0.91 [− 1.67, − 0.15]
|
Large
|
Kell et al. 2009 [34]
|
Good
|
− 0.87 [− 1.85, 0.10]
|
Large
|
Overall 12–16 weeks
| |
− 0.61 [− 1.21, 0.00]
|
Moderate
| |
Overall pain
| |
− 0.41 [− 0.72, − 0.10]
|
Small
|
Strong
|
Disability
|
ODI and PSFS
|
6–8 weeks
|
Aasa et al. 2015 [30]
|
Good
|
− 0.38 [− 0.85, 0.09]
|
Small
|
Moderate
|
Atalay et al. 2017 [36]
|
Fair
|
− 0.22 [− 1.10, 0.66]
|
Small
|
Cai et al. 2015 [31]
|
Good
|
0.15 [− 0.40, 0.70]
|
Trivial
|
Suh et al. 2019 [35]
|
Good
|
− 0.05 [− 0.88, 0.77]
|
Trivial
|
Overall 6–8 weeks
| |
− 0.15 [− 0.46, 0.16]
|
Trivial
| |
12–16 weeks
|
Cortell-Tormo et al. 2018 [14]
|
Good
|
− 0.91 [− 1.76, − 0.06]
|
Large
|
Strong
|
Hurley et al. 2015 [32]
|
Good
|
− 0.02 [− 0.35, 0.31]
|
Trivial
|
Jackson et al. 2011 [MA] [33]
|
Good
|
− 0.74 [− 1.49, 0.00]
|
Moderate
|
Jackson et al. 2011 [OA] [33]
|
Good
|
− 0.75 [− 1.49, − 0.00]
|
Moderate
|
Kell et al. 2009 [34]
|
Good
|
− 0.75 [− 1.72, 0.21]
|
Moderate
|
Overall 12–16 weeks
| |
− 0.53 [− 0.97, − 0.09]
|
Moderate
| |
Overall LOD
| |
− 0.31 [− 0.56, − 0.06]
|
Small
|
Strong
|
Strength
|
6–8 weeks
|
Aasa et al. 2015 [30]
|
Good
|
0.19 [− 0.28, 0.66]
|
Trivial
|
Conflicting
|
Atalay et al. 2017 [36]
|
Fair
|
0.41 [− 0.48, 1.30]
|
Small
|
Cai et al. 2015 [31]
|
Good
|
0.51 [− 0.04, 1.07]
|
Moderate
|
Overall 6–8 weeks
| |
0.34 [0.00, 0.67]
|
Small
| |
12–16 weeks
|
Jackson et al. 2011 [MA] [33]
|
Good
|
0.67 [− 0.07, 1.41]
|
Moderate
|
Strong
|
Jackson et al. 2011 [OA] [33]
|
Good
|
0.67 [− 0.07, 1.40]
|
Moderate
|
Kell et al. 2009 [34]
|
Good
|
0.68 [− 0.28, 1.64]
|
Moderate
|
Overall 12–16 weeks
| |
0.67 [0.21, 1.13]
|
Moderate
| |
Overall strength
| |
0.45 [0.18, 0.72]
|
Small
|
Strong
|